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Abstract
 
Helicobacter pylori
 
 toxin, VacA, damages the gastric epithelium by erosion and loosening of tight
junctions. Here we report that VacA also interferes with T cell activation by two different mech-
anisms. Formation of anion-specific channels by VacA prevents calcium influx from the extracellular
milieu. The transcription factor NF-AT thus fails to translocate to the nucleus and activate key
cytokine genes. A second, channel-independent mechanism involves activation of intracellular
signaling through the mitogen-activated protein kinases MKK3/6 and p38 and the Rac-specific
nucleotide exchange factor, Vav. As a consequence of aberrant Rac activation, disordered actin
polymerization is stimulated. The resulting defects in T cell activation may help 
 
H. pylori
 
 to
prevent an effective immune response leading to chronic colonization of its gastric niche.
Key words: MAP kinase signaling cascades • immunosuppression • host–pathogen interactions • 
calcium signaling
 
Introduction
 
Chronic infection by the gastric pathogen 
 
Helicobacter pylori
 
causes peptic ulcer disease and is associated with gastric
cancer (1). 
 
H. pylori
 
 produces a protein exotoxin, VacA,
which causes vacuolar degeneration of epithelial cells in
vitro and is believed to play an important role in the erosion of
the gastric epithelium leading to ulcer formation (2, 3).
VacA binds to target cells and then is slowly internalized to
the cytoplasm where it is found associated with internal
membrane-bound compartments (4, 5). Vacuole biogenesis
requires the activity of the Rab7 GTPase and the V-type
ATPase. VacA treatment also causes reduction in transepi-
thelial resistance in epithelial monolayers in vitro (6). In
addition, VacA interferes with cells of the immune system
by inhibiting antigen processing in APCs, resulting in altered
epitope presentation and recognition by effector cells (7),
suggesting that VacA may contribute to the capacity of 
 
H.
pylori
 
 to evade immune surveillance and chronically colonize
the gastric mucosa.
More recently, VacA has been shown to form anion-
selective channels both in artificial membranes (8) and in
patch-clamped epithelial cells (9), which can be blocked by
chloride channel inhibitors. Both vacuolating activity and
transepithelial resistance reduction are suppressed by chloride
channel inhibitors, and it has been suggested that anion
channel formation could account for all of the biological
activity of VacA (9). Several lines of evidence indicate that
the initial interaction of VacA with its target cells is
through a high affinity receptor (5, 10), which facilitates its
interaction with the cell membrane to form the channels
which are subsequently internalized. Three cell surface
proteins have been implicated as specific receptors for
VacA. In some cell types, the receptor-like tyrosine phos-
phatase RPTP
 
 
 
 has been shown to be required for cell
vacuolation by VacA(11) and gastric damage (12). More
recently, a second tyrosine phosphatase, RPTP
 
 
 
, has also
been shown to act as a VacA receptor (13). Furthermore,
some evidence implicates the epidermal growth factor recep-
tor in VacA-induced pathology (14). On the other hand,
both high affinity, saturable binding and low affinity, non-
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saturable binding of VacA to some cell types has been de-
scribed (10). Since VacA can interact directly with artificial
membranes in the absence of specific receptors (15), it is
likely that VacA interaction with target cells is complex and
may involve both specific receptors and direct interaction
with lipid components of the membrane.
VacA is released from the bacteria as high molecular
weight homooligomers of a 
 
 
 
90-kD polypeptide observ-
able as flower-like structures by electron microscopy (16).
In the hydrophobic environment of artificial membranes,
VacA forms hexameric structures, which are likely to rep-
resent the ion channels (17). After release from the bacteria,
each 90-kD oligomer undergoes slow proteolytic cleavage
at a specific site in an exposed loop to produce two frag-
ments of 
 
 
 
35 and 58 kD (18). DNA transfection experi-
ments have demonstrated that a NH
 
2
 
-terminal fragment of
the protein containing the 35-kD fragment plus 
 
 
 
110
amino acids of the 58-kD fragment (p58) are necessary and
sufficient for vacuolation (19). On the other hand, p58
produced in 
 
H. pylori
 
 binds epithelial cells with similar ki-
netics to the holotoxin but lacks vacuolating activity and,
in fact, does not enter the cell (20). Fig. 1 A shows the
structure of the 
 
vacA
 
 gene and protein.
Although mice immunized with a variety of 
 
H. pylori
 
 an-
tigens, including VacA, are protected from challenge, the
robust immune response induced in man during natural 
 
H.
pylori
 
 infection fails to prevent chronic colonization (21).
The objective of this study was to assess whether, in addi-
tion to its activity on APCs, VacA might interfere with the
immune system by interacting with T lymphocytes. The
results demonstrate that VacA interferes with T cell activa-
tion by two independent mechanisms, only one of which is
blocked by chloride channel inhibitors. The second activ-
ity, which appears independent of internalization as it is
also induced by p58, may involve interaction with a spe-
cific receptor.
 
Materials and Methods
 
Cells, Reagents, Plasmids, and Antibodies.
 
Cells included the T
lymphoma Jurkat line, a stably transfected Jurkat line expressing lu-
ciferase under the control of a trimer of the distal NF-AT binding
site on the IL-2 promoter (22), the human leukemic line HL-60,
and human PBL. HL-60 cells were used as such or following dif-
ferentiation into macrophage-like cells by treatment for 48 h with
20 ng/ml PMA (23). PBMCs were purified from whole blood by
density gradient centrifugation and subsequently depleted of
monocytes by adherence. Monocytes were recovered for further
analysis. Neutrophils were enriched by centrifugation on Dextran.
Polarized human CD4
 
 
 
 Th clones were generated as described
(24). Clones producing IFN-
 
 
 
 and TNF-
 
 
 
 were categorized as
Th1, and clones producing IL-4 and IL-5 were categorized as Th2.
They were maintained in culture by periodical restimulation (ev-
ery 12 d) with PHA (2.5 
 
 
 
g/ml) and rIL-2 (25 U/ml; Eurocetus)
in the presence of irradiated PBMCs as feeder cells. IL-2 was re-
placed every 3 d to allow growth. All VacA binding experiments
were performed on Th clones 1 d before restimulation.
VacA was purified from the culture supernatant of 
 
H. pylori
 
strain CCUG17874 by ion exchange chromatography and size
 
exclusion as described (25). VacA was activated by a short treat-
ment at pH 2.0 before use (26). The 58-kD COOH-terminal
fragment of VacA which extends from amino acid 330 to the end
of the mature protein was purified from the culture supernatant
of a 
 
H. pylori
 
 strain from which the DNA sequences encoding
most of the NH
 
2
 
-terminal portion had been removed by allelic
exchange (20). In some experiments, VacA (10–40 
 
 
 
g/ml) was
preincubated for 30 min on ice with 100 
 
 
 
g/ml neutralizing anti-
VacA or irrelevant rabbit Ig before addition to the cells. Alterna-
tively, VacA/p58 (20 
 
 
 
g/ml) was immunodepleted by preincu-
bation for 30 min on ice with 100 
 
 
 
g/ml neutralizing anti-VacA
or irrelevant Ig and protein A–Sepharose (Amersham Bio-
sciences). After removal of immune complexes by centrifugation,
the supernatant was tested for residual activity. A23187 was from
Roche Diagnostics SpA, ionomycin and 5-nitro-2-(3-phenylpro-
pylamino)-benzoic acid (NPPB) were from Sigma-Aldrich, and
Fluo-3 was from Molecular Probes Europe BV.
The anti-VacA mAb was made from a hybridoma (C1G9) pro-
duced from a mouse immunized with native highly purified VacA
(27). The antibody, which recognizes a conformational epitope in
the native toxin and the 58-kD COOH-terminal fragment, was
protein G purified from the hybridoma supernatant. Neutralizing
rabbit anti-VacA Ig were described previously (25). Phosphospe-
cific antibodies recognizing the active forms of p38, Erk1/2, and
MKK 3/6 were from Cell Signaling Technology, anti-p38 and
anti-Erk antibodies were from Santa Cruz Biotechnology, an-
tiphosphotyrosine mAb, anti–
 
cyclooxygenase (
 
COX)-2 poly-
clonal antibodies, and anti-Vav poly- and monoclonal antibodies
were from Upstate Biotechnology. Fluorochrome-labeled anti-
CD69 mAb and annexin V were from Becton Dickinson. IgG
from OKT3 (anti-CD3; American Type Culture Collection) hy-
bridoma supernatants were protein G purified. Unlabeled second-
ary antibodies were from Cappel, peroxidase-labeled antibodies
were from Amersham Biosciences, and FITC-labeled anti–mouse
antibodies were from DAKO SpA. Sepharose-conjugated GST-
Pak and anti-Rac mAb were from Upstate Biotechnology, and
PE-labeled phalloidin was from Sigma-Aldrich.
 
Transfections, Confocal Microscopy, and Flow Cytometry.
 
Jurkat
cells were transiently transfected with the plasmid pEGFP/NFAT-
1D (28) using a modification of the DEAE/dextran procedure as
described (29). Each experiment was performed at least three
times. Cells were treated for 30 min or 6 h at 37
 
 
 
C with 500 ng/
ml A23187. Alternatively, anti-CD3 mAb was cross-linked for the
same times at 37
 
 
 
C with secondary antibody. When VacA or p58
was used, cells were incubated for 1 h on ice with 5–40 
 
 
 
g/ml
VacA or 40 
 
 
 
g/ml p58 and then further incubated on ice for 30
min with excess anti-VacA mAb in the presence or absence of
anti-CD3 mAb. After washing, cells were added with either sec-
ondary antibodies and, when required, A23187, and further incu-
bated at 37
 
 
 
C as described above. To analyze cortical actin reorga-
nization, cells were either treated with anti-CD3 mAb or VacA/
anti-VacA mAb as described above, and bound antibodies were
cross-linked with secondary antibodies for 15 min at 37
 
 
 
C. Cells
were then fixed and permeabilized in Orthopermeafix™ (Ortho-
diagnostic Systems Inc.) for 45 min at RT. After washing, cells
were incubated in the dark for 40 min with 0.77 
 
 
 
M FITC-
labeled phalloidin. Confocal microscopy was performed on a
Leica Microsystems confocal microscope.
VacA/p58 binding was analyzed by indirect immunofluores-
cence. Cells were incubated on ice for 1 h with different concen-
trations of VacA/p58. After washing, cells were incubated with
anti-VacA mAb followed, after a further wash, by FITC-labeled
anti–mouse antibodies, and processed for flow cytometry. Nega- 
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tive controls included either VacA/p58 or anti-VacA mAb, each
in combination with fluorochrome-labeled secondary antibodies.
CD69 surface expression was quantitated using FITC-labeled anti-
CD69 mAb. Samples were processed using a FACScan flow cy-
tometer (Becton Dickinson). Calcium flux was measured as de-
scribed using fluo-3 (30). Fluorescence was recorded continuously
for 512 s. To analyze the effect of VacA/p58 on calcium influx in-
duced by A23187, fluo-3–loaded cells, resuspended in HBSS
added with Mg
 
2
 
 
 
 and Ca
 
2
 
 
 
, were incubated for 20 min at RT
with 20 
 
 
 
g/ml VacA or 40 
 
 
 
g/ml p58. After washing, anti-VacA
mAb was added and incubated for 10 min at RT before addition
of A23187. When NPPB was used, fluo-3–loaded cells were pre-
incubated for 2 min with inhibitor or carrier before subsequent
additions. Apoptosis was analyzed by flow cytometry by labeling
cells with FITC-labeled annexin V and 50 
 
 
 
g/ml propidium io-
dide as described (31) and gating on annexin V
 
 
 
PI
 
 
 
 cells.
 
Activations, Immunoprecipitations, Immunoblots, and Luciferase As-
says.
 
For immunoprecipitation and immunoblot experiments,
activations by TCR–CD3 ligation in solution were performed as
described by binding of anti-CD3 mAb on ice and subsequent
cross-linking for 1–5 min with secondary antibodies at 37
 
 
 
C (29).
When VacA or p58 were used, cells were incubated for 1 h on ice
with different concentrations of these proteins, washed, and incu-
bated on ice for a further 30 min with anti-VacA mAb in the pres-
ence or absence of anti-CD3 mAb followed, after a wash, by
cross-linking with secondary antibodies for at 37
 
 
 
C. Alternatively,
anti-CD3 mAb and excess secondary antibodies were added si-
multaneously and cross-linked for 5 min at 37
 
 
 
C. When VacA or
p58 were used, cells were incubated for 30 min at 37
 
 
 
C with
VacA and excess anti-VacA mAb, followed by a further 5 min at
37
 
 
 
C with excess secondary antibodies. Nonactivated samples
were processed as above with either secondary antibodies or anti-
VacA mAb and secondary antibodies. Cells (2 
 
 
 
 10
 
6
 
 cells/sample)
were lysed in 1% (vol/vol) Triton X-100 in 20 mM Tris-HCl, pH
8, 150 mM NaCl (in the presence of 0.2 mg/ml Na orthovana-
date, 1 
 
 
 
g/ml pepstatin, leupeptin, and aprotinin and 10 mM
PMSF) and resolved by SDS-PAGE. Alternatively, postnuclear su-
pernatants from 2.5–5 
 
 
 
 10
 
7
 
 cells/sample were immunoprecipi-
tated using the appropriate polyclonal antibodies and protein
A–Sepharose. Rac activity was measured by in vitro binding assays of
postnuclear supernatants from 10
 
7
 
 cells/sample using a GST–Pak1
fusion, which specifically pulls down GTP-bound, active Rac fol-
lowed by immunoblot with an anti-Rac mAb. Immunoblots were
performed using peroxidase-labeled secondary antibodies and a
chemiluminescence detection kit (Pierce Chemical Co.).
NF-AT/luciferase reporter Jurkat cells were activated by CD3
cross-linking on secondary antibody-coated plates as described
(29) using anti-CD3 Ab alone or in combination with VacA or
 
Figure 1.
 
VacA binding on Jurkat T cells and human PBL and Th cells.
(A) Schematic representation of the 
 
vacA
 
 gene and VacA protein. The
3,888-bp 
 
vacA
 
 gene from 
 
H. pylori
 
 strain CCUG17874 is represented
showing regions encoding the signal peptide (sp), the 37-kD (p37) and
58-kD (p58) natural proteolytic fragments separated by the short hydro-
philic region containing the cleavage site (loop), and the outer membrane
autotransporter (exporter). Below is represented the mature secreted protein
showing the two domains connected by a flexible loop. The arrow in-
dicates the site of proteolytic cleavage between p37 and p58. (B) Flow
cytometric analysis of VacA and p58 binding to purified human PBL
(left) or Jurkat T cells (middle, right). VacA and p58 concentrations were
40 
 
 
 
g/ml (460 nM) and 80 
 
 
 
g/ml (1,365 nM), respectively. (C) Titration of
VacA binding to PBL (left) or Jurkat cells (right) by flow cytometry. The
data are expressed as mean fluorescence intensity (MFI). (D) Residual
VacA or p58 binding to Jurkat cells after immunodepletion with either
neutralizing anti-VacA or irrelevant (asp) Ig (starting VacA/p58 concen-
tration 20 
 
 
 
g/ml, Ig 100 
 
 
 
g/ml). The data, obtained by flow cytometry,
are expressed as the percentage of binding of the same concentration of
untreated VacA/p58. (E) Flow cytometric analysis of VacA/p58 (40 
 
 
 
g/ml)
binding to HL-60 cells, either untreated or incubated for 48 h with carrier or
20 ng/ml PMA. (F) Flow cytometric analysis of VacA binding to Th1 and
Th2 cells, either unstimulated (0) or after 16-h stimulation with plastic-bound
anti-CD3 mAb (CD3). Two representative Th1/Th2 clones are shown. 
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p58. In the latter case, cells were incubated for 1 h on ice with
VacA or p58, then added with anti-VacA mAb, incubated a fur-
ther 30 min on ice, and plated on secondary antibody-coated
plates. When required, NPPB or carrier was added 10 min before
activation. Cells were collected 6–8 h after activation and pro-
cessed for luciferase assays as described (22). All samples were in
duplicate, and each experiment was repeated three to five times.
Induction of CD69 expression by CD3 ligation in the presence
or absence of VacA/p58 was performed as above, but cells were
processed for flow cytometry 16–24 h after activation. Analysis of
COX-2 expression was performed on neutrophils and macro-
phages treated with VacA for 24 h as described for T cells. LPS
activation of macrophages was performed by incubation for 10
min at 37
 
 
 
C with 10 
 
 
 
g/ml LPS.
 
Immunohistochemistry.
 
The use of gastric tissue for this study
was approved by the Institutional and Ethical Review Boards and
written informed consent was obtained from each patient before
gastric sampling. Gastric specimens were formalin fixed from five
patients infected by 
 
H. pylori
 
 type I strains and five healthy con-
trols. Peroxidase staining was conducted with the ABC elite
kit  from Vector Laboratories. Mouse anti–phospho-p38 mAb
(28B10) was from Cell Signaling Technology.
 
Results
 
VacA Binds to T Cells.
 
Fig. 1 shows VacA binding to T
cells. Indirect immunofluorescence labeling and flow cyto-
metric analysis of VacA-treated cells using a mAb against a
conformational epitope in the p58 domain (27) revealed ex-
tensive binding both to Jurkat T cells and to freshly isolated
PBL (Fig. 1 B) including both CD4
 
 
 
 and CD8
 
 
 
 subsets
(not depicted). A dose–response curve showed a rapid in-
crease in VacA binding at low concentrations followed by a
slower increase which did not reach saturation (Fig. 1 C).
These kinetics most likely reflect the previously described
interactions with a high affinity receptor and low affinity,
nonsaturable interactions (10). As shown for other cell types
(20), p58 also bound to Jurkat cells albeit at lower levels
than intact VacA (Fig. 1 B). That the binding activity re-
vealed is in fact due to VacA or p58 has been confirmed by
immunodepletion experiments using a VacA-specific neu-
tralizing antiserum raised against intact native VacA (25)
(Fig. 1 D). Furthermore, VacA and p58 binding to HL-60
cells increased substantially after treatment with phorbol es-
ter consistent with the increase in sensitivity to VacA de-
scribed by Padilla et al. (23), further supporting the specific-
ity of the assay (Fig. 1 E). VacA binding to human Th1 and
Th2 clones, allowed to come to rest in the absence of IL-2,
was also detectable. Interestingly, TCR–CD3 ligation on
both Th1 and Th2 clones resulted in increase of VacA bind-
ing by up to 50-fold (Fig. 1 F).
 
VacA Inhibits T Cell Activation.
 
Cell surface expression
of the T cell activation marker CD69 is highly up-regu-
lated by TCR–CD3 ligation. Fig. 2 shows that treatment
with VacA completely inhibited the CD3-induced expres-
sion of CD69 on the T cell surface. Incubation with p58
resulted in reduction of CD69 expression (Fig. 2 A, right).
Furthermore, VacA treatment inhibited CD69 expression
on both CD4
 
 
 
 and CD8
 
 
 
 subsets of human PBL (Fig. 2
B). Hence VacA appears to effectively block TCR–CD3-
dependent T cell activation. The inhibitory activity of
VacA was not due to effects on cell viability nor to trigger-
ing of apoptosis as assayed by annexin V and propidium io-
dide staining (not depicted).
 
VacA Inhibits NF-AT Activation.
 
NF-AT is a key tran-
scription factor which becomes active within the first hour
after TCR triggering and is essential for T cell activation
and their subsequent capacity to express IL-2 and other cy-
tokines (32). We assessed the capacity of VacA to inhibit
this early stage of T cell activation. As a readout for NF-AT
activation, we used a Jurkat cell line stably transfected with
a luciferase gene under the control of a synthetic NF-AT–
dependent promoter (22). VacA inhibited activation of the
reporter by CD3 cross-linking in a dose–responsive fashion
(Fig. 3 A). Cells were quite sensitive to VacA, which
caused 
 
 
 
80% reduction of luciferase activity at a concen-
tration of 
 
 
 
50 nM, similar to that required to achieve full
vacuolation in epithelial cell lines. Inhibition of NF-AT ac-
tivation was independent of VacA cross-linking with anti-
body (Fig. 3 C), was reduced significantly by preincubation
with neutralizing anti-VacA antiserum (
 
 
 
30% residual in-
hibition at 20 
 
 
 
g/ml), and heat-inactivation of VacA abro-
gated the inhibitory effect (Fig. 3 C). No vacuoles were
visible in the VacA-treated cells, although vacuolation may
not have been detected because of the small size of the cy-
toplasm (not depicted). Pretreatment of the cells with the
chloride channel inhibitor NPPB completely abrogated the
effect of VacA such that CD3-dependent luciferase activity
was not significantly different from that induced in the ab-
sence of VacA (Fig. 3 E). These data indicate that the effect
Figure 2. VacA inhibits the induction of CD69 surface expression in
response to TCR–CD3 engagement. (A) Flow cytometric analysis of
CD69 expression on Jurkat cells activated for 16 h by CD3 cross-linking in
the presence or absence of either 20  g/ml VacA or 40  g/ml p58. (B)
CD69 expression on human PBL activated for 24 h by CD3 cross-linking
in the presence or the absence of 20  g/ml VacA. Cells were counter-
stained with fluorochrome-labeled anti-CD4 or anti-CD8 mAb, and CD69
expression was measured on gated CD4  (left) or CD8  (right) T cells. 
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of VacA is specific and dependent on its capacity to form
ion channels in the cell membranes.
To confirm this hypothesis p58, which has no vacuolat-
ing activity and is not internalized in epithelial cells (20),
was tested. Treatment of Jurkat cells with p58 at concentra-
tions similar to those used for VacA had negligible effect on
CD3-induced NF-AT activity. At higher concentrations,
p58 treatment resulted in some inhibition, reaching 50–
60% inhibition at 10-fold higher concentration (Fig. 3 B).
The inhibition was specific to p58, since it was completely
abrogated by preincubation with neutralizing anti-VacA
antiserum (Fig. 3 D). However, inhibition of chloride
channels with NPPB failed to reverse the p58 effect (Fig. 3
E), suggesting that VacA may have two different effects on
T cell activation, of which only one is dependent on ion
channel formation and internalization.
 
NF-AT Fails to Translocate to the Nucleus in the Presence of
VacA.
 
Two independent intracellular signals triggered by
the TCR–CD3 complex are required for NF-AT activa-
tion (32). On the one hand, an increase in [Ca
 
2
 
 
 
] activates
the phosphatase calcineurin which dephosphorylates the
cytoplasmic form of NF-AT, resulting in its accumulation
in the nucleus. On the other hand, triggering of tyrosine
kinases (PTKs) leads to activation of the Ras/mitogen-acti-
vated protein kinase (MAPK) signaling pathway and phos-
phorylation of both the AP-1 transcription factor and nu-
clear NF-AT, which cooperate to activate transcription.
The effect of VacA on NF-AT nuclear translocation was
assessed using Jurkat cells transiently transfected with a con-
struct encoding a NF-AT–GFP fusion protein. The results
are presented in Fig. 3 F. In untreated cells, fluorescence
was detected in the cytoplasm but was completely excluded
from the nucleus. CD3 cross-linking resulted in transloca-
tion of fluorescence to the nucleus. VacA completely
blocked the nuclear translocation of NF-AT induced by
anti-CD3 cross-linking. Inhibition of translocation per-
sisted even after 6-h treatment (unpublished data). Re-
markably, VacA blocked NF-AT translocation induced by
A23187, a powerful calcium ionophore which results in
massive increase of [Ca
 
2
 
 
 
] independently of TCR signal-
 
Figure 3.
 
Inhibition of CD3-dependent NF-AT activation and nuclear
translocation by VacA. Relative luciferase activity in NFAT/luciferase
reporter Jurkat cells activated by CD3 cross-linking (CD3 XL) in the
presence of different concentrations of VacA (A) or p58 (B). Luciferase
activity induced by CD3 cross-linking in the absence of VacA was taken
as 100%. (C) Relative luciferase units (RLU) in reporter Jurkat cells acti-
vated by CD3 cross-linking in the presence or absence of 20 
 
 
 
g/ml
VacA. VacA was either cross-linked using anti-VacA mAb and plate-
bound secondary antibodies (VacA XL) or bound to Jurkat cells and
plated on secondary antibodies without anti-VacA mAb (VacA noXL).
VacA hi, heat-inactivated VacA (boiled 5 min), cross-linked. (D) Relative
luciferase activity (percentage of activity triggered by CD3 cross-linking)
in reporter Jurkat cells activated by CD3 cross-linking in the presence or
 
absence of 20 
 
 
 
g/ml p58. p58 was used either as such or after preincubation
with 100 
 
 
 
g/ml neutralizing anti-VacA (p58
 
  
 
-VacA) or irrelevant Ig
(p58
 
 
 
asp Ig) and cross-linked using anti-VacA mAb and plate-bound
secondary antibodies. (E) Relative luciferase units (RLU) in reporter Jurkat
cells activated by CD3 cross-linking in the presence or absence of 20  g/ml
VacA or 80  g/ml p58 and NPPB (100  M). VacA was cross-linked using
anti-VacA mAb and plate-bound secondary antibodies. NPPB was added
10 min before anti-CD3 mAb or VacA. (F) Confocal microscopy of Jurkat
cells transiently transfected with a NFAT–GFP expression construct, either
unstimulated (0) or after treatment with 500 ng/ml A23187 or CD3
cross-linking for 30 min, either in the absence or the presence of 40  g/ml
VacA/p58. In the neutralization assay, VacA (10  g/ml) was used either
as such or after preincubation with 100  g/ml neutralizing anti-VacA
(A VacA  -VacA) or irrelevant Ig (A VacA asp Ig). A23187 induced
nuclear translocation in  100% of cells. In the presence of VacA, no cells
showed nuclear staining. Pretreatment of VacA with neutralizing anti-VacA
antiserum resulted in  80% translocation versus  15% translocation in
the presence of nonspecific Ig (number of fluorescent cells scored  50).T Lymphocyte Suppression by H. pylori Cytotoxin 1892
ing. Preincubation of VacA with neutralizing antiserum ab-
rogated the VacA-dependent block of translocation. Of
note, p58 did not affect CD3-dependent NF-AT transloca-
tion. Thus, while the dramatic effects of VacA on NF-AT
translocation explain the complete abrogation by VacA of
NF-AT–dependent luciferase expression, a different mech-
anism appears to underlie the inhibitory activity of p58 on
NF-AT activation.
VacA Blocks Increases in Intracellular Calcium. Jurkat cells
were loaded with the calcium-sensitive fluorescent dye
fluo-3 then treated with A23187 and VacA. In the absence
of VacA, A23187 caused a massive increase in intracellular
[Ca2 ], which was strongly inhibited by VacA (Fig. 4 A).
VacA also inhibited calcium flux caused by a second car-
boxylic ionophore, ionomycin (not depicted). Hence, the
inhibition of agonist-induced NF-AT translocation to the
nucleus by VacA can be attributed to its capacity to block
the increase in [Ca2 ]i. In agreement with its lack of effect
on NF-AT translocation, p58 did not affect calcium mobili-
zation induced by A23187 (Fig. 4 B). In the presence of
NPPB, VacA had no effect on the A23187-induced increase
in [Ca2 ] (Fig. 4 C), suggesting that the opening of anion
channels can influence calcium influx and that these chan-
nels contribute to the regulation of intracellular [Ca2 ].
Although the block of TCR-induced [Ca2 ] by VacA is
sufficient to explain its inhibition of T cell activation, the
fact that p58 also inhibits induction of CD69 expression
and NF-AT activation independently of anion channel for-
mation and calcium influx indicates that VacA may have
two independent activities on these cells. Since p58 binds
to cells but is not internalized (20), its activity may be due
to interaction with cell surface receptors and activation of
intracellular signaling pathways.
VacA Triggers Signaling to p38 Stress Kinase. TCR sig-
naling through the TCR–CD3 complex results in rapid
PTK activation which leads to phosphorylation of several
cytoplasmic proteins. This cascade leads to activation of the
Ras/MAPK pathway and subsequently to phosphorylation
and activation of transcription factors such as AP-1 which
interacts with nuclear NF-AT to form a functional het-
erodimer. In addition, these signals lead to actin cytoskele-
ton rearrangements necessary for the functional interaction
between T cell and APC (33). Interestingly, treatment of
Jurkat cells with VacA resulted in substantial increase of
tyrosine phosphoproteins independent of TCR triggering
(Fig. 5 A), suggesting that VacA affects the activity of
PTKs. However, the pattern of phosphotyrosine-contain-
ing bands was different to that achieved by activation
through the TCR. In fact, a discrete subset of the proteins
phosphorylated after TCR triggering were phosphorylated
in response to VacA.
Two major classes of MAPK, the “classical” MAPK rep-
resented by Erk 1/2 and the related stress-activated kinase
p38 become phosphorylated in response to TCR trigger-
ing, and both are essential for T cell activation (34). We
have assessed the effect of VacA treatment on these kinases
using antibodies which recognize specifically the phosphor-
ylated, active forms of the proteins. Treatment of Jurkat
cells with VacA had no effect on either the basal or CD3-
induced phosphorylation of Erk1/2 (Fig. 5 B). However
VacA did result in substantial increase in tyrosine phos-
phorylation of the stress-activated kinase p38 even in the
absence of CD3 cross-linking. Fig. 5 C shows anti–phos-
pho-p38 blots of protein extracts from Jurkat cells treated
with different VacA concentrations. p38 was activated to
the level achieved by CD3 cross-linking by incubation
with  1  g/ml VacA, which is considerably less than that
required for NF-AT inhibition in Jurkat cells or vacuola-
tion in HeLa cells. No effect on p38 phosphorylation was
observed when cells were treated with heat-inactivated
VacA (Fig. 5 C). Of note, p58 also caused activation of p38
Figure 4. Anion channel-dependent inhibition of calcium mobilization
by VacA. (A) Flow cytometric analysis of intracellular calcium flux in
fluo-3–loaded Jurkat cells treated with 500 ng/ml A23187 in the absence
or the presence of 20  g/ml VacA. MFI is shown in the top corner of
each panel. (B) Flow cytometric analysis of intracellular calcium flux in
fluo-3–loaded Jurkat cells treated with 500 ng/ml A23187 in the absence
or the presence of 20  g/ml VacA or 40  g/ml p58. The data are ex-
pressed as fold increase of fluorescence after addition of A23187. (C) Flow
cytometric analysis showing the MFI of fluo-3–loaded Jurkat cells after
treatment with A23187 (A, 500 ng/ml) and 20  g/ml VacA in the presence
or absence of NPPB (50  M).Boncristiano et al.  1893
in Jurkat cells with a dose response similar to that of VacA
(Fig. 5 D). Preincubation with anti-VacA neutralizing anti-
bodies or immunodepletion of VacA/p58 reduced the ef-
fect elicited by both VacA and p58 (Fig. 5 E and not de-
picted). The capacity of p58 to activate p38 indicates that
p38 activation is independent of the chloride channel activ-
ity of VacA. In support of this, NPPB did not affect p38
activation by VacA (Fig. 5 F).
Major activators of p38 in T cells are the serine-threonine
kinases MKK3/6 which in turn are linked to transmem-
brane signaling molecules through Vav, an exchange factor
specific for Rho family GTPases (35, 36). VacA treatment
of Jurkat cells resulted in phosphorylation of these mole-
cules. Fig. 6 shows anti–phospho-MKK3/6 blots of cell ex-
tracts (A) and antiphosphotyrosine blots of Vav-specific im-
munoprecipitates (B) from Jurkat cells treated with VacA.
VacA induced substantial phosphorylation of MKK3/6 and
a prolonged Vav phosphorylation for up to 15 min. Vav ac-
tivation by VacA was not inhibited by NPPB (Fig. 6 C), in-
dicating that this effect is also independent of its chloride
channel activity. These data strongly support the notion that
VacA interacts with a cell surface receptor which is linked
to the Vav-MKK3/6-p38 signaling pathway.
VacA Induces Rac1-dependent Cytoskeleton Rearrangement.
Vav is coupled to reorganization of the actin cytoskeleton
through its exchange activity on the small GTPase Rac (35).
Rac1 has also been implicated in VacA-induced vacuolation
in epithelial cells (37). Fig. 6 D shows the results of assays of
Rac activity in VacA-treated T cells. VacA treatment sub-
stantially increased Rac activity within 1 min of treatment.
The effect of this activation could also be observed directly
by its effect on cortical actin distribution in VacA-treated
cells. Fig. 6 E shows fluorescence micrographs of VacA or
anti-CD3–treated cells stained with phalloidin which specif-
ically binds F-actin. Both VacA and CD3 cross-linking
caused massive actin reorganization. This effect of VacA was
not inhibited by NPPB (not depicted).
p38 Is Activated in H. pylori–colonized Gastric Mucosa.
To assess the in vivo relevance of p38 activation, gastric
sections from H. pylori–infected patients were stained for
phosphorylated p38. Gastric biopsies were obtained from
five H. pylori–infected subjects and five healthy H. pylori–
negative volunteers. Phospho-p38 was detected in glandu-
lar epithelial and lymphomononuclear-like cells in sections
from all five H. pylori–infected patients but not from any of
the healthy H. pylori–noninfected subjects (Fig. 7 A).
VacA Activates p38 in Neutrophils and Macrophages.
Since extensive staining of infiltrating inflammatory cells
was observed, we questioned whether VacA was capable of
activating p38 in other immune cells. Neutrophils and
macrophages were enriched from human blood and treated
with VacA, and p38 activation was assayed by immunoblot
analysis of cell lysates with anti–phospho-p38 antibodies. In
both cell types, VacA treatment resulted in substantial acti-
vation of p38 (Fig. 7 B), indicating that activation of this
kinase is not limited to T cells but also occurs in other cell
Figure 5. Activation of protein tyrosine phosphorylation and p38 activation by VacA. (A) Antiphosphotyrosine immunoblot of postnuclear supernatants
from Jurkat cells either nonactivated (0) or activated by cross-linking of CD3 or 40  g/ml VacA. (B–F) Immunoblot analysis of postnuclear supernatants
from Jurkat cells, nonactivated (0) or activated by either TCR–CD3 (CD3) or VacA or p58 cross-linking in the presence or absence of 100  M NPPB.
hi, heat-inactivated VacA; no XL, VacA and secondary antibodies without anti-VacA mAb. The concentration of VacA used in B (right) and F was 40
and 5  g/ml, respectively. In E, VacA or p58 were tested either as such or after immunodepletion with neutralizing anti-VacA or irrelevant (asp) Ig
(starting VacA/p58 concentration 20  g/ml, Ig 100  g/ml). Similar differences could be observed when cells where treated with VacA or p58 in the
presence of neutralizing or control Ig (not depicted). Each filter was probed by immunoblot with anti–phospho-Erk (B) or anti–phospho-p38 (C–F)
antibodies. After stripping, all filters were reprobed with control antibodies as indicated.T Lymphocyte Suppression by H. pylori Cytotoxin 1894
types known to infiltrate the gastric epithelium during H.
pylori colonization. Heat-inactivated VacA had no effect
(not depicted).
A consequence of p38 activation in macrophages and
neutrophils is increased expression of COX-2, which con-
tributes to inflammation by production of proinflammatory
prostanoids (38). VacA treatment induced increased expres-
sion of COX-2 in these cells (Fig. 7 C). Together, these
data suggest that VacA may also play a role in H. pylori–
induced gastric inflammation.
Discussion
Two considerations emerge from the data reported here.
On the one hand, we describe signaling pathways which
are modulated by VacA in T cells and which may be rele-
vant to the interaction of VacA with other cell types in
vivo as clearly exemplified by the induction of p38 activity
and COX-2 expression in neutrophils and macrophages, as
well as the presence of phospho-p38 in gastric biopsies
from H. pylori–positive patients. On the other hand, the
profound effect on T cell activation caused by VacA may
play a role in vivo in preventing an appropriate protective
immune response against infection by H. pylori and thus
contribute to the chronicity of colonization.
The ability of VacA to block modulation of intracellular
calcium is likely to have profound effects on many cell
types in vivo. In T cells, calcium influx from extracellular
sources is essential for cell activation, proliferation, and ac-
tivation of effector functions (39). The major channels em-
ployed by T cells to elicit the prolonged increase in [Ca2 ]
in response to TCR triggering are the store-operated cal-
cium (CRAC) channels. The driving force for calcium in-
flux through CRAC channels and by carboxylic iono-
phores is membrane potential. The most likely explanation
of the inhibitory activity of VacA on calcium influx is that
it causes membrane depolarization by opening unregulated
anion channels (8). This is supported by the fact that the
chloride channel blocker NPPB restored calcium flux in
the presence of VacA.
We have demonstrated a second activity of VacA on T
cells which is independent of its channel-forming capacity
and involves activation of a subset of the PTKs normally
activated by TCR engagement. This leads to activation of
p38 stress kinase but not of Erk1/2. NPPB had no effect on
this activity, and the channel-defective p58 mutant was
fully active in these assays. It should be noted that maximal
p38 kinase activation was achieved at VacA concentrations
well below those required to inhibit NF-AT through
channel formation and hence could reflect an important re-
sponse to limited VacA.
PTK triggering is usually triggered by cell surface recep-
tors although forced coalescence of lipid rafts by cross-link-
ing of cholera toxin bound to GM1 ganglioside in rafts can
mimic TCR signaling (40, 41). Both these mechanisms
could play a role in VacA activation of PTK activity. VacA
has been shown recently to interact with lipid rafts in cells
of a gastric epithelial line; however, VacA-induced raft co-
alescence was not demonstrated (42). On the other hand,
VacA interacts with the receptor tyrosine phosphatases,
RTPT  and RTPT  (11, 13), in gastric cell lines, and
these receptors are known to be present on the surface of T
Figure 6. Activation of MKK3/6 and the Vav/Rac pathway of actin
cytoskeleton reorganization by VacA. (A) Immunoblot analysis of post-
nuclear supernatants from Jurkat cells, nonactivated (0) or activated by
either TCR–CD3 (CD3) or VacA (40  g/ml) cross-linking, with anti–
phospho-p38 and anti–phospho-MKK3/6 antibodies. (B) Immunoblot
analysis using antiphosphotyrosine mAb of Vav-specific immunoprecipitates
from Jurkat cells activated by TCR–CD3 or VacA cross-linking as in A
for 15 s or 15 min (C) Immunoblot analysis using antiphosphotyrosine
mAb of Vav-specific immunoprecipitates from Jurkat cells activated by
TCR–CD3 or VacA cross-linking as in A for 15 s in the presence or absence
of 100  M NPPB (1-h pretreatment before addition of VacA). (D) Immuno-
blot analysis with anti-Rac mAb of in vitro binding assays of postnuclear
supernatants from Jurkat cells using agarose-conjugated Pak1-GST. Equal
amounts of postnuclear supernatants from the same samples were separated
on the same gel (right). Cells were either nonactivated (0) or activated by
cross-linking of CD3 (30 s) or 40  g/ml VacA (30 s and 1 min). All filters
were stripped and reprobed with control antibodies as indicated. (E) Confo-
cal microscopy of FITC-phalloidin–labeled Jurkat cells. Cells were either
nonactivated (0) or activated by cross-linking of CD3 or 20  g/ml VacA
for 15 min.Boncristiano et al.  1895
cells. Surprisingly, however, gastric cells isolated from
RTPT  /  mice were equally susceptible to VacA vacu-
olation as cells from WT siblings, although gastric epithelial
damage by VacA was significantly reduced in the knockout
mice (43). Tyrosine phosphatases are involved in both acti-
vation and feedback control of the PTK cascade in T cells
(44). Thus, the partial activation of kinases in T cells by
VacA could be due to activation of RPTP /  or other
VacA receptor molecules.
The capacity of VacA to induce intracellular signaling and
to activate p38 in inflammatory cells such as neutrophils and
macrophages may play an important role in H. pylori patho-
genesis. It is of note that the concentration of VacA re-
quired to activate p38 in T cells was much lower than that
required for the channel-dependent activity or that required
for epithelial cell vacuolation. Thus, the channel-dependent
activity may be more relevant close to the VacA-producing
bacteria, whereas the signaling activity may be more rele-
vant at sites further removed where concentrations are
lower. VacA-triggered signaling through RPTP  was also
demonstrated in gastric epithelial cells. In these experiments,
VacA caused detachment of epithelial cells from the base-
ment membrane in WT mice but not RPTP  /  mice
(43). This phenomenon may be related to the Rac-depen-
dent actin cytoskeleton rearrangement described here.
Regardless of the mechanism of kinase activation by
VacA, the rearrangement of actin cytoskeleton induced
through Vav/Rac activation outside of the normal context
of T cell activation is likely to interfere with the ordered re-
arrangement required for the formation of the immunologi-
cal synapse between T cells and APCs (45). Actin reorgani-
zation is essential also for the coalescence of lipid rafts
containing the TCR–CD3 complex and important signaling
molecules and the resulting triggering of the kinase cascade
(41, 46). Subversion of signaling to the actin cytoskeleton by
modification of Rho family GTPases, resulting in their inhi-
bition or activation, is in fact a common denominator
among bacterial toxins, including Clostridium difficile toxin B,
C. sordellii lethal toxin, and cytotoxic necrotizing factor-1 of
uropathogenic Escherichia coli strains (47).
Infection with H. pylori induces a vigorous systemic im-
mune response which is, however, insufficient to prevent
colonization of its gastric niche. Disease is associated with a
Th1 response in the gastric mucosa, and this is believed to
be partially responsible for the gastric inflammation charac-
teristic of H. pylori–induced disease (24). Both oral and sys-
temic immunization with purified antigens and an appro-
priate adjuvant can nevertheless confer protection against
Figure 7. p38 activity is detectable in gastric biopsies of H. pylori–positive
patients and in VacA-treated neutrophils and macrophages. (A) Immuno-
histochemistry of activated p38 in gastric mucosa of H. pylori–infected
patient. Phosphorylated p38 antigens are identified by brown peroxidase
staining. No staining was observed in the absence of primary antibody
(not depicted). (Top) Healthy H. pylori–negative control (no positive
anti–phospho-p38 staining). (Bottom) H. pylori–infected patient (positive
anti–phospho-p38 staining). Original magnification 40 . (B) Immunoblot
analysis with anti–phospho-p38 antibodies of postnuclear supernatants
from purified human neutrophils or macrophages treated with 20  g/ml
VacA for 5 or 10 min as indicated. (C) Immunoblot analysis with anti–
COX-2 antibodies of postnuclear supernatants from purified human
neutrophils or macrophages treated with 20  g/ml VacA for 24 h. Macro-
phages activated with 10  g/ml LPS were used as a positive control. After
stripping, all filters were reprobed with control antibodies as indicated.T Lymphocyte Suppression by H. pylori Cytotoxin 1896
challenge in animal models and can even force eradication
of chronically colonized mice in a therapeutic setting (48).
This would suggest that H. pylori can either avoid evoking
the appropriate immune response on infection or has
mechanisms by which to control the response at least lo-
cally. VacA has been demonstrated to interfere with anti-
gen presentation in B cells by inhibiting correct proteolytic
processing of internalized antigens and presentation of the
resulting peptides by MHC (7). It has been suggested that
this activity may play a role in immune evasion. Suppres-
sion or modification of T cell responses by VacA-depen-
dent modulation of signaling during T cell activation or
differentiation might represent an additional effective strat-
egy of immune evasion by H. pylori.
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